Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil (2022)
- Authors:
- USP affiliated authors: OLIVEIRA, CLAUDIA PINTO MARQUES SOUZA DE - FM ; CARRILHO, FLAIR JOSÉ - FM
- Unidade: FM
- DOI: 10.4254/wjh.v14.i1.195
- Subjects: ANTIVIRAIS; HEPATITE VIRAL HUMANA; HEPATITE CRÔNICA; CIRROSE HEPÁTICA
- Language: Inglês
- Imprenta:
- Publisher place: Pleasanton
- Date published: 2022
- Source:
- Título do periódico: World journal of hepatology
- ISSN: 1948-5182
- Volume/Número/Paginação/Ano: v. 14, n. 1, 2022
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc
-
ABNT
LOURENCO, Mariana Sandoval et al. Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil. World journal of hepatology, v. 14, n. 1, 2022Tradução . . Disponível em: https://doi.org/10.4254/wjh.v14.i1.195. Acesso em: 04 maio 2024. -
APA
Lourenco, M. S., Zitelli, P. M. Y., Cunha-silva, M., Oliveira, A. I. N., Oliveira, C. P. M. S. de, Seva-pereira, T., et al. (2022). Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil. World journal of hepatology, 14( 1). doi:10.4254/wjh.v14.i1.195 -
NLM
Lourenco MS, Zitelli PMY, Cunha-silva M, Oliveira AIN, Oliveira CPMS de, Seva-pereira T, Carrilho FJ, Pessoa MG, Mazo DF. Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil [Internet]. World journal of hepatology. 2022 ; 14( 1):[citado 2024 maio 04 ] Available from: https://doi.org/10.4254/wjh.v14.i1.195 -
Vancouver
Lourenco MS, Zitelli PMY, Cunha-silva M, Oliveira AIN, Oliveira CPMS de, Seva-pereira T, Carrilho FJ, Pessoa MG, Mazo DF. Direct-acting antivirals for chronic hepatitis C treatment: The experience of two tertiary university centers in Brazil [Internet]. World journal of hepatology. 2022 ; 14( 1):[citado 2024 maio 04 ] Available from: https://doi.org/10.4254/wjh.v14.i1.195 - S-Nitroso-N-acetylcysteine induces de-differentiation of activated hepatic stellate cells and promotes antifibrotic effects in vitro
- Microsomal triglyceride transfer protein (MTP) 493 G/T polymorphism is associated with insulin resistance in chronic hepatitis (CHC) genotype infection
- Genetic ancestry analysis in non-alcoholic fatty liver disease patients from Brazil and Portugal
- Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and high plasma homocysteine in chronic hepatitis C (CHC) infected patients from the Northeast of Brazil
- Yo Jyo Hen Shi Ko (YHK) Modulates the Expression of Proteins Involved in de novo Lipogenesis and Lipid Exportation in Experimental Nonalcoholic Steatohepatitis (NASH)
- Clinical patterns of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) ]Editorial]: a multicenter prospective study
- Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population
- Impact of current diet at the risk of non-alcoholic fatty liver disease (NAFLD)
- The Antibody response to hepatitis B virus vaccination is not influenced by the hepatitis C virus viral load in patients with chronic hepatitis C
- Combination of N-acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non-alcoholic steatohepatitis
Informações sobre o DOI: 10.4254/wjh.v14.i1.195 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
